| Literature DB >> 32772318 |
Pablo A Slullitel1, Carlos M Lucero2, Maria L Soruco3, Jorge D Barla3, Javier A Benchimol4, Bruno R Boietti4,5, Gerardo Zanotti2, Fernando Comba2, Danilo R Taype-Zamboni3, Guido S Carabelli3, Francisco Piccaluga2, Carlos F Sancineto3, Maria Diehl6, Martin A Buttaro2.
Abstract
PURPOSE: To analyse the impact of prolonged mandatory lockdown due to COVID-19 on hip fracture epidemiology.Entities:
Keywords: COVID-19; Frailty; Hemiarthroplasty; Hip fracture; Mortality; Readmissions; Total hip arthroplasty
Mesh:
Year: 2020 PMID: 32772318 PMCID: PMC7414899 DOI: 10.1007/s00264-020-04769-6
Source DB: PubMed Journal: Int Orthop ISSN: 0341-2695 Impact factor: 3.075
Demographic data of the series divided by group
| Variable | Total cohort ( | Pre-COVID time fractures ( | COVID time fractures ( | |
|---|---|---|---|---|
| Median age (IQR) | 86 (79–91) | 86 (78–90) | 86 (80–91) | 0.83 |
| Female patients (%) | 132 (82.5%) | 67 (78%) | 65 (88%) | 0.1 |
| Median BMI (IQR) | 24.5 (22–27) | 24 (21.7–26.6) | 24.5 (22.3–27.3) | 0.11 |
| Median time (hours) to rRT-PCR (IQR) | – | – | 6 (3–19) | – |
| ASA score (%) | ||||
| I–II | 34 (21.3%) | 22 (25.6%) | 12 (16.2%) | |
| III–IV | 126 (78.7%) | 64 (74.4%) | 62 (84%) | 0.15 |
| CCI (%) | ||||
| Mild | 4 (2.5%) | 3 (3.5%) | 1 (1.3%) | |
| Moderate | 44 (27.5%) | 31 (36%) | 13 (17.6%) | |
| Severe | 111 (69.4%) | 52 (60.5%) | 59 (79.7%) | 0.03 |
| Median UCLA scale (IQR) | 3 (2–4) | 3 (2–4) | 2 (2–3) | 0.037 |
| Median IADL score (IQR) | 4 (2–6) | 5 (3–6) | 3 (1.75–4) | 0.001 |
| Rockwood Frailty Score ≥ 5 (%) | 74 (46.3%) | 32 (37.2%) | 42 (56.8%) | 0.013 |
BMI, body mass index; rRT-PCR, reverse transcriptase-polymerase chain reaction; IQR, interquartile range; ASA, American Society of Anesthesia; CCI, Charlson Comorbidity Index; UCLA, University of California Los Angeles Activity scale; IADL, Instrumented Activities of Daily Living
Fig. 1Graph showing median time to surgery for hip fracture resolution during pre-COVID and COVID timeframes with their corresponding 95%CIs
Surgical variables divided by group
| Variable | Total cohort ( | Pre-COVID time fractures ( | COVID time fractures ( | |
|---|---|---|---|---|
| Median time (hours) to surgery (IQR) | 24 (12.25–36) | 16.5 (9–30) | 24 (24–48) | 0.0001 |
| Median surgical time (minutes) (IQR) | 45 (32.7–60) | 45 (40–60) | 40 (30–60) | 0.17 |
| Type of fracture (%) | ||||
| 31A1 | 25 (16%) | 19 (22.1%) | 6 (8.1%) | |
| 31A2 | 48 (30%) | 22 (25.6%) | 26 (35.1%) | |
| 31A3 | 5 (3.1%) | 0 | 5 (3.1%) | |
| 32A1 | 2 (1.25%) | 0 | 2 (1.25%) | |
| 32A2 | 2 (1.25%) | 0 | 2 (1.25%) | |
| Displaced neck of femur | 66 (41.3%) | 35 (40.7%) | 31 (41.9%) | |
| Undisplaced neck of femur | 12 (7.5%) | 10 (11.7%) | 2 (2.7%) | 0.004 |
| Type of implant (%) | ||||
| Cannulated screws | 13 (8.1%) | 11 (12.8%) | 2 (2.75%) | |
| Hemiarthroplasty | 34 (21.3%) | 14 (16.3%) | 20 (27%) | |
| THA | 29 (18.1%) | 19 (22.1%) | 10 (13.5%) | |
| Girdlestone | 1 (0.6%) | 1 (1.1%) | 0 | |
| IM nail | 82 (51.2%) | 41 (47.7%) | 41 (55.4%) | |
| Not operated | 1 (0.6%) | 0 | 1 (1.35%) | 0.04 |
| Median length (days) of stay (IQR) | 5 (4–7) | 5 (4–7) | 6 (5–8) | 0.001 |
IQR, interquartile range; THA, total hip arthroplasty; IM, intramedullary
Fig. 2Graph depicting the type of implant distribution during pre-COVID and COVID timeframes
Complications, readmissions and mortality outcomes divided by group
| Variable | Total cohort ( | Pre-COVID time fractures ( | COVID time fractures ( | |
|---|---|---|---|---|
| Intraoperative periprosthetic fracture | 3 (1.88%) | 1 (1.16%) | 2 (2.7%) | 0.43 |
| Dislocation (%) | 1 (0.63%) | 0 | 1 (1.35%) | 0.34 |
| Surgical site infection (%) | 2 (1.25%) | 2 (2.32%) | 0 | 0.45 |
| Thromboembolic disease (%) | 5 (3.13%) | 0 | 5 (6.75%) | 0.014 |
| Readmission (%) | 15 (9.38%) | 7 (8.1%) | 8 (10.8%) | 0.56 |
| FUO | 1 | 2 | ||
| Cholecystitis | 0 | 1 | ||
| Ischemic stroke | 0 | 1 | ||
| 1 | 1 (deceased) | |||
| LGB | 0 | 1 | ||
| PDD | 2 | 2 | ||
| LRTI | 2 | 0 | ||
| PJI | 1 | 0 | ||
| CHF | ||||
| Mortality (%) | 8 (5%) | 0 | 8 (10.8%) | 0.002 |
FUO, fever of unknown origin; LGB, low gastrointestinal bleeding; PDD, psychiatric disorder decompensation; LRTI, lower respiratory tract infection; PJI, periprosthetic joint infection; CHF, congestive heart failure
Fig. 3Graph portraying correlation between in-hospital stay and the advent of thromboembolic disease (TED) per timeframe
Risk factors for mortality
| Variable | Odds risk | 95% Confidence interval | |
|---|---|---|---|
| ASA | 2.88 | 0.18–4.33 | 0.453 |
| Charlson score | 0.61 | 0.22–1.68 | 0.338 |
| Frailty index | 10.46 | 8.95–16.1 | 0.006 |
| Time to surgery | 1.03 | 0.99–1.08 | 0.093 |
| Thromboembolic disease | 30 | 11–42 | 0.005 |
| UCLA scale | 2.45 | 1.45–2.72 | 0.018 |
| IADL score | 0.35 | 0.12–1.07 | 0.066 |